GE Healthcare Technologies Inc (GEHC) Stock Forecast & Price Target

Compare

1,752 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

GEHC Analyst Ratings

Moderate Buy

8 Buy

5 Hold

1 Sell

Based on 14 analysts giving stock ratings to

Healthcare Technologies Inc

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

GEHC Stock 12 Month Forecast

Average Price Target

$91.33

▲(7.07% Upside)

Based on 14 Wall Street analysts offering 12 month price targets for GE Healthcare Technologies Inc in the last 3 months. The average price target is $91.33 with a high forecast of $105.00 and a low forecast of $77.00. The average price target represents a 7.07% change from the last price of $85.30.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"66":"$66","76":"$76","86":"$86","96":"$96","106":"$106"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":105,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$105.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":91.33,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$91.33</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":77,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$77.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[66,76,86,96,106],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Apr<br/>2025","6":"Jul<br/>2025","9":"Oct<br/>2025","12":"Jan<br/>2026","25":"Jan<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.987,83.75723076923076,85.52746153846154,87.2976923076923,89.06792307692308,90.83815384615384,92.60838461538461,94.37861538461539,96.14884615384615,97.91907692307691,99.6893076923077,101.45953846153846,103.22976923076924,{"y":105,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.987,82.7056923076923,83.42438461538461,84.14307692307692,84.86176923076923,85.58046153846153,86.29915384615384,87.01784615384615,87.73653846153846,88.45523076923077,89.17392307692307,89.89261538461538,90.61130769230769,{"y":91.33,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,81.987,81.60338461538461,81.21976923076923,80.83615384615385,80.45253846153845,80.06892307692307,79.68530769230769,79.3016923076923,78.91807692307692,78.53446153846154,78.15084615384615,77.76723076923076,77.38361538461538,{"y":77,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":78.005,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":88.138,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":87.19,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.424,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 8, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":67.581,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":70.058,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.85,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":69.79,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":73.667,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 24, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.445,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 36, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.92,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 32,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 28, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":79.208,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.987,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$105.00

Average Price Target$91.33

Lowest Price Target$77.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Graham Doyle

UBS

$73→$77

Sell

-9.73%

Downside

Downgraded

01/15/26

GE HealthCare downgraded to Sell from Neutral at UBSGE HealthCare downgraded to Sell from Neutral at UBS

Joanne Wuensch

Citi

Hold

―

Reiterated

01/14/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Bicara Therapeutics Inc. (NASDAQ: BCAX), NewAmsterdam Pharma Company (NASDAQ: NAMS) and GE Healthcare Technologies Inc (NASDAQ: GEHC)

David Roman

Goldman Sachs

$86→$98

Buy

14.89%

Upside

Reiterated

01/09/26

GE HealthCare price target raised to $98 from $86 at Goldman SachsGE HealthCare price target raised to $98 from $86 at Goldman Sachs

Rick Wise

Stifel Nicolaus

$90→$95

Buy

11.37%

Upside

Reiterated

01/07/26

GE Healthcare Technologies Inc (GEHC) Gets a Buy from Stifel Nicolaus

Travis Steed

Bank of America Securities

$82→$92

Hold

7.85%

Upside

Reiterated

01/05/26

Bank of America Securities Keeps Their Hold Rating on GE Healthcare Technologies Inc (GEHC)

Vijay Kumar

Evercore ISI

$92→$95

Buy

11.37%

Upside

Reiterated

01/05/26

GE HealthCare price target raised to $95 from $92 at Evercore ISIGE HealthCare price target raised to $95 from $92 at Evercore ISI

Larry Biegelsen

Wells Fargo

$95

Buy

11.37%

Upside

Reiterated

12/12/25

Wells Fargo Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Matthew Taylor

Jefferies

$95→$105

Buy

23.09%

Upside

Reiterated

12/11/25

Jefferies Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)

Matt Miksic

Barclays

$86

Hold

0.82%

Upside

Reiterated

12/05/25

Barclays Reaffirms Their Hold Rating on GE Healthcare Technologies Inc (GEHC)

Ryan Zimmerman

BTIG

$87

Buy

1.99%

Upside

Reiterated

12/02/25

Analysts Are Bullish on Top Healthcare Stocks: vTv Therapeutics (VTVT), Theravance Biopharma (TBPH)

Robbie Marcus

J.P. Morgan

Hold

―

Reiterated

11/20/25

GE Healthcare's Intelerad Acquisition: Balancing Long-term Growth with Short-term EPS Dilution

Patrick Wood

Morgan Stanley

$80

Hold

-6.21%

Downside

Reiterated

11/20/25

GE Healthcare's Strategic Acquisition of Intelerad: Balancing Long-Term Gains with Short-Term Challenges

Jason Bednar

Piper Sandler

$91

Buy

6.68%

Upside

Reiterated

11/18/25

Piper Sandler Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

$95

Buy

11.37%

Upside

Reiterated

10/30/25

Navann Ty

Exane BNP Paribas

$92

Buy

7.85%

Upside

Reiterated

09/10/25

GE Healthcare Technologies Inc (GEHC) Receives a Buy from Exane BNP Paribas

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Graham Doyle

UBS

$73→$77

Sell

-9.73%

Downside

Downgraded

01/15/26

GE HealthCare downgraded to Sell from Neutral at UBSGE HealthCare downgraded to Sell from Neutral at UBS

Joanne Wuensch

Citi

Hold

―

Reiterated

01/14/26

David Roman

Goldman Sachs

$86→$98

Buy

14.89%

Upside

Reiterated

01/09/26

GE HealthCare price target raised to $98 from $86 at Goldman SachsGE HealthCare price target raised to $98 from $86 at Goldman Sachs

Rick Wise

Stifel Nicolaus

$90→$95

Buy

11.37%

Upside

Reiterated

01/07/26

GE Healthcare Technologies Inc (GEHC) Gets a Buy from Stifel Nicolaus

Travis Steed

Bank of America Securities

$82→$92

Hold

7.85%

Upside

Reiterated

01/05/26

Bank of America Securities Keeps Their Hold Rating on GE Healthcare Technologies Inc (GEHC)

Vijay Kumar

Evercore ISI

$92→$95

Buy

11.37%

Upside

Reiterated

01/05/26

GE HealthCare price target raised to $95 from $92 at Evercore ISIGE HealthCare price target raised to $95 from $92 at Evercore ISI

Larry Biegelsen

Wells Fargo

$95

Buy

11.37%

Upside

Reiterated

12/12/25

Wells Fargo Keeps Their Buy Rating on GE Healthcare Technologies Inc (GEHC)

Matthew Taylor

Jefferies

$95→$105

Buy

23.09%

Upside

Reiterated

12/11/25

Jefferies Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)

Matt Miksic

Barclays

$86

Hold

0.82%

Upside

Reiterated

12/05/25

Barclays Reaffirms Their Hold Rating on GE Healthcare Technologies Inc (GEHC)

Ryan Zimmerman

BTIG

$87

Buy

1.99%

Upside

Reiterated

12/02/25

Analysts Are Bullish on Top Healthcare Stocks: vTv Therapeutics (VTVT), Theravance Biopharma (TBPH)

Robbie Marcus

J.P. Morgan

Hold

―

Reiterated

11/20/25

GE Healthcare's Intelerad Acquisition: Balancing Long-term Growth with Short-term EPS Dilution

Patrick Wood

Morgan Stanley

$80

Hold

-6.21%

Downside

Reiterated

11/20/25

GE Healthcare's Strategic Acquisition of Intelerad: Balancing Long-Term Gains with Short-Term Challenges

Jason Bednar

Piper Sandler

$91

Buy

6.68%

Upside

Reiterated

11/18/25

Piper Sandler Sticks to Its Buy Rating for GE Healthcare Technologies Inc (GEHC)

Unknown Analyst

Mizuho Securities

Not Ranked

Mizuho Securities

$95

Buy

11.37%

Upside

Reiterated

10/30/25

Navann Ty

Exane BNP Paribas

$92

Buy

7.85%

Upside

Reiterated

09/10/25

GE Healthcare Technologies Inc (GEHC) Receives a Buy from Exane BNP Paribas

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering GE Healthcare Technologies Inc

3 Months

xxx

Success Rate

10/12 ratings generated profit

Average Return

+1.43%

reiterated a xxx

rating 9 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 83.33% of your transactions generating a profit, with an average return of +1.43% per trade.

1 Year

Matthew TaylorJefferies

Success Rate

5/6 ratings generated profit

Average Return

+7.98%

reiterated a buy rating last month

Copying Matthew Taylor's trades and holding each position for 1 Year would result in 83.33% of your transactions generating a profit, with an average return of +7.98% per trade.

2 Years

xxx

Success Rate

5/6 ratings generated profit

Average Return

+8.22%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 83.33% of your transactions generating a profit, with an average return of +8.22% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

GEHC Analyst Recommendation Trends

Rating

Sep 25

Oct 25

Nov 25

Dec 25

Jan 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, GEHC has received 17 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. GEHC average Analyst price target in the past 3 months is 91.33.

Each month's total comprises the sum of three months' worth of ratings.

GEHC Financial Forecast

GEHC Earnings Forecast

Next quarter’s earnings estimate for GEHC is $1.39 with a range of $1.20 to $1.46. The previous quarter’s EPS was $1.07. GEHC beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Sales Forecast

Next quarter’s sales forecast for GEHC is $5.61B with a range of $5.48B to $5.70B. The previous quarter’s sales results were $5.14B. GEHC beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year GEHC has Performed in-line its overall industry.

GEHC Stock Forecast FAQ

What is GEHC’s average 12-month price target, according to analysts?

Based on analyst ratings, GE Healthcare Technologies Inc’s 12-month average price target is 91.33.

What is GEHC’s upside potential, based on the analysts’ average price target?

GE Healthcare Technologies Inc has 7.07% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is GEHC a Buy, Sell or Hold?

GE Healthcare Technologies Inc has a consensus rating of Moderate Buy which is based on 8 buy ratings, 5 hold ratings and 1 sell ratings.

What is GE Healthcare Technologies Inc’s price target?

The average price target for GE Healthcare Technologies Inc is 91.33. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $105.00 ,the lowest forecast is $77.00. The average price target represents 7.07% Increase from the current price of $85.3.

What do analysts say about GE Healthcare Technologies Inc?

GE Healthcare Technologies Inc’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.

How can I buy shares of GEHC?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

GE Healthcare Technologies Inc (GEHC) Stock Forecast & Price Target

GEHC Analyst Ratings

GEHC Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering GE Healthcare Technologies Inc

GEHC Analyst Recommendation Trends

GEHC Financial Forecast

GEHC Earnings Forecast

GEHC Sales Forecast

GEHC Stock Forecast FAQ

Detailed List of Analyst Forecasts